Farkas Charles 4
4 · CONMED Corp · Filed Sep 9, 2024
Insider Transaction Report
Form 4
CONMED CorpCNMD
Farkas Charles
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-05$39.64/sh+1,000$39,640→ 20,880 total - Exercise/Conversion
SARs (Stock Appreciation Rights)
2024-09-05−1,000→ 0 totalExercise: $39.64From: 2015-06-01Exp: 2024-09-11→ Common Stock (1,000 underlying) - Tax Payment
Common Stock
2024-09-05$74.31/sh−534$39,682→ 20,346 total
Footnotes (1)
- [F1]The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs vesting on June 1, 2015 and expiring on September 11, 2024.